Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: The Bogalusa Heart Study

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 175-182

  Chen, Wei ^a   Srinivasan, Sathanur R ^a   Boerwinkle, Eric ^b   Berenson, Gerald S ^a  

^a TULANE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Black white; C 514T polymorphism; HDL cholesterol; Hepatic lipase gene; Longitudinal changes

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE;

ADOLESCENT; ADULT; ADULTHOOD; AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; BASAL METABOLIC RATE; CARDIOVASCULAR RISK; CHILD; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; COMMUNITY CARE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; MALE; MOLECULAR INTERACTION; NORMAL HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SAMPLING; SEX RATIO; STATISTICAL SIGNIFICANCE;

EID: 0037630608     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00162-X     Document Type: Article

References (55)

1. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., Jacobs D.R. Jr, Bangdiwala S., Tyroler H.A. High density lipoprotein cholesterol and disease: four prospective American studies. Circulation. 79:1989;8-15.
2. Tall A.R. Plasma high-density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86:1990;379-384.
3. Fan J., Watanabe T. Hepatic lipase. J. Atheroscler. Thromb. 5:1998;41-45.
4. Thuren T. Hepatic lipase and HDL metabolism. Curr. Opin. Lipidol. 11:2000;277-283.
5. Deckelbaum R.J., Ramakrishnan R., Eisenberg S., Olivecrona T., Bengtsson-Olivecrona G. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry. 31:1992;8544-8551.
6. Shirai K., Barnhart R.L., Jackson R.L. Hydrolysis of human plasma high density lipoprotein 2-phospholipids and triglycerides by hepatic lipase. Biochem. Biophys. Res. Commun. 100:1981;591-599.
7. Cohen J.C., Vega G.L., Grundy S.M. Hepatic lipase: new insights from genetic and metabolic studies. Curr. Opin. Lipidol. 10:1999;259-267.
8. Cooper A.D. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38:1997;2173-2192.
9. Hegele R.A., Little J.A., Vezina C., Maguire G.F., Tu L., Wolever T.S., Jenkins D.J., Connelly P.W. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13:1993;720-728.
10. Vega G.L., Clark L.T., Tang A., Marcovina S., Grundy S.M., Cohen J.C. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res. 39:1998;228-232.
11. Carr M.C., Hokanson J.E., Zambon A., Deeb S.S., Barrett P.H.R., Purnell J.Q., Brunzell J.D. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J. Clin. Endocrinol. Metab. 86:2001;2831-2837.
12. Applebaum-Bowden D., Haffner S.M., Wahl P.W., Hoover J.J., Warnick G.R., Albers J.J., Hazzard W.R. Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis. 5:1985;273-282.
13. Friday K.E., Srinivasan S.R., Elkasabany A., Dong C., Wattigney W.A., Dalferes E. Jr, Berenson G.S. Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men. Metabolism. 48:1999;749-754.
14. Kuusi T., Kesaniemi Y.A., Vuoristo M., Miettinen T.A., Koskenvuo M. Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis. 7:1987;421-425.
15. Perusse L., Rice T., Despres J.P., Bergeron J., Province M.A., Gagnon J., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., Bouchard C. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE family study. Arterioscler. Thromb. Vasc. Biol. 17:1997;3263-3269.
16. Guerra R., Wang J., Grundy S.M., Cohen J.C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. 94:1997;4532-4537.
17. Cohen J.C., Wang Z., Grundy S.M., Stoesz M.R., Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94:1994;2377-2384.
18. Hide W.A., Chan L., Li W.H. Structure and evolution of the lipase superfamily. J. Lipid Res. 33:1992;167-178.
19. van't Hooft F.M., Lundahl B., Ragogna F., Karpe F., Olivecrona G., Hamsten A. Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler. Thromb. Vasc. Biol. 20:2000;1335-1339.
20. Botma G.J., Verhoeven A.J., Jansen H. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by upstream stimulatory factor. Atherosclerosis. 154:2001;625-632.
21. Jansen H., Chu G., Ehnholm C., Dallongeville J., Nicaud V., Talmud P.J. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European atherosclerosis research study (EARS) II. Arterioscler. Thromb. Vasc. Biol. 19:1999;303-308.
22. Jansen H., Verhoeven A.J., Weeks L., Kastelein J.J., Halley D.J., van den Ouweland A., Jukema J.W., Seidell J.C., Birkenhager J.C. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17:1997;2837-2842.
23. Zambon A., Deeb S.S., Hokanson J.E., Brown B.G., Brunzell J.D. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler. Thromb. Vasc. Biol. 18:1998;1723-1729.
24. Tahvanainen E., Syvanne M., Frick M.H., Murtomaki-Repo S., Antikainen M., Kesaniemi Y.A., Kauma H., Pasternak A., Taskinen M.R. Ehnholm C for the LOCAT study investigators. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J. Clin. Invest. 101:1998;956-960.
25. Deeb S.S., Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J. Lipid Res. 41:2000;155-158.
26. Couture P., Otvos J.D., Cupples L.A., Lahoz C., Wilson P.W.F., Schaefer E.J., Ordovas J.M. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 20:2000;815-822.
27. Shohet R.V., Vega G.L., Anwar A., Cigarroa J.E., Grundy S.M., Cohen J.C. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease: allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler. Thromb. Vasc. Biol. 19:1999;1975-1978.
28. Riemens S.C., van Tol A., Scheek L.M., Dullaart R.P.F. Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subjects. Scand. J. Clin. Lab. Invest. 61:2001;1-10.
29. Juo S.H., Han Z., Smith J.D., Colangelo L., Liu K. Promoter polymorphisms of the hepatic lipase gene influence HDL2 but not HDL3 in African-American men: CARDIA study. J. Lipid Res. 42:2001;258-264.
30. De Oliveirae Silva E.R., Kong M., Han Z., Starr C., Kass E.M., Juo S.H., Foster D., Dansky H.M., Merkel M., Cundey K., Brinton E.A., Breslow J.L., Smith J.D. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J. Lipid Res. 40:1999;1211-1221.
31. Tan K.C., Shiu S.W., Chu B.Y. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese. Atherosclerosis. 157:2001;233-239.
32. Inazu A., Nishimura Y., Terada Y., Mabuchi H. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population. J. Hum. Genet. 46:2001;172-177.
33. Carr M.C., Ayyobi A.F., Murdoch S.J., Deeb S.S., Brunzell J.D. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler. Thromb. Vasc. Biol. 22:2002;667-673.
34. Yamakawa-Kobayashi K., Somekawa Y., Fujimura M., Tomura S., Arinami T., Hamaguchi H. Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy. Atherosclerosis. 162:2002;17-21.
35. Berenson G.S., McMahan C.A., Voors A.W., Webber L.S., Srinivasan S.R., Frank G.C., Foster T.A., Blonde C.V. Cardiovascular risk factors in children. The early natural history of atherosclerosis and essential hypertension. 1980;Oxford University Press, Oxford.
36. Srinivasan S.R., Berenson G.S. Serum lipoproteins in children and methods for study. Lewis L.A. CRC handbook of electrophoresis volume III lipoprotein methodology and human studies. 1983;185-203 CRC Press, Boca Raton, FL.
37. Lipid Research Clinics Program. Manual of Laboratory Operations, vol. 1: lipid and lipoprotein analysis, DHEW Publication no (NIH) 75-628, Washington, DC: National Institutes of Health, 1974.
38. Lee L.G., Connell C.R., Bloch W. Allele discrimination by nick translation PCR with fluorogenic probes. Nucleic Acids Res. 21:1993;3761-3766.
39. SAS Institute. SAS/STAT user's guide, version 6, 4th ed., Cary NC, SAS Institute, 1994.
40. SAS Institute. SAS/STAT software: changes and enhancements through release 6.12, Cary, NC, SAS Institute, 1997.
41. Neter J., Wasserman W., Kutner M.H. Applied linear statistical models. Regression, analysis of variance and experimental designs. 3rd ed:1990;225-236 IRWIN, Homewood, IL and Boston, MA.
42. Murtomaki S., Tahvanainen E., Antikainen M., Tiret L., Nicaud V., Jansen H., Ehnholm C. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European atherosclerosis research study. Arterioscler. Thromb. Vasc. Biol. 17:1997;1879-1884.
43. Connelly P.W. The role of hepatic lipase in lipoprotein metabolism. Clin. Chim. Acta. 286:1999;243-255.
44. Rye K.A., Clay M.A., Barter P.J. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis. 145:1999;227-238.
45. Deckelbaum R.J., Ramakrishnan R., Eisenberg S., Olivecrona T., Bengtsson-Olivecrona G. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry. 31:1992;8544-8551.
46. Applebaum-Bowden D. Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism. Curr. Opin. Lipidol. 6:1995;130-135.
47. Tikkanen M.J., Nikkila E.A. Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am. Heart J. 113:1987;562-567.
48. Vega G.L., Gao J., Bersot T.P., Mahley R.W., Verstraete R., Grundy S.M., White A., Cohen J.C. The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. J. Lipid Res. 39:1998;1520-1524.
49. Clay M.A., Newnham H.H., Barter P.J. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler. Thromb. 11:1991;415-422.
50. Donahue R.P., Jacobs D.R. Jr, Sidney S., Wagenknecht L.E., Albers J.J., Hulley S.B. Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study. Arteriosclerosis. 9:1989;656-664.
51. Srinivasan S.R., Wattigney W., Webber L.S., Berenson G.S. Race and gender differences in serum lipoproteins of children, adolescents, and young adults - emergence of an adverse lipoprotein pattern in white males: the Bogalusa Heart Study. Prev. Med. 20:1991;671-684.
52. Grundy S.M., Vega G.L., Otvos J.D., Rainwater D.L., Cohen J.C. Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J. Lipid Res. 40:1999;229-234.
53. Ordovas J.M., Corella D., Demissie S., Cupples L.A., Couture P., Coltell O., Wilson P.W., Schaefer E.J., Tucker K.L. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham study. Circulation. 106:2002;2315-2321.
54. Dugi K.A., Brandauer K., Schmidt N., Nau B., Schneider J.G., Mentz S., Keiper T., Schaefer J.R., Meissner C., Kather H., Bahner M.L., Fiehn W., Kreuzer J. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation. 104:2001;3057-3062.
55. Hokanson J.E., Cheng S., Snell-Bergeon J.K., Fijal B.A., Grow M.A., Hung C., Erlich H.A., Ehrlich J., Eckel R.H., Rewers M. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes. 51:2002;1208-1213.